Omentin - a new adipokine with many roles to play[sub][/sub]
Journal Title: Current Issues in Pharmacy and Medical Sciences - Year 2015, Vol 28, Issue 3
Abstract
DOI: 10.1515/cipms-2015-0067 Adipose tissue is at a point of high interest in medical research, not only as an energy depot, but also because it secretes nearly more than 600 cytokines. These are termed‚ adipokines’. Human adipokines are involved in numerous metabolic processes, including the regulation of appetite, energy expenditure, insulin sensitivity, inflammation and cardiovascular activity. Thus, these could be clinically important as a markers of adipose tissue function and increased metabolic risk. The search for novel adipokines linking obesity to related co-morbidities has become a major topic in obesity research. In such work, there is an increasing need to define their function, their molecular targets and their potential clinical relevance as biomarkers or in the treatment of obesity and other metabolic diseases. Omentin (34 kDa) is a recently identified fat deposition-specific adipokine with multiple interactions. Concentrations of omentin have been shown to be decreased in patients with obesity and impaired glucose regulation, in patients afflicted with diabetes type 1 and 2, and in patients with polycystic ovary syndrome. These are all diseases commonly associated with insulin resistance and obesity. The aim of this study was to show and compare the latest information about omentin and its relationships with obesity, diabetes mellitus (DM), metabolic syndrome (MetS), inflammation, cardiac problems, sex hormone imbalances and cancer. The association of omentin with particular metabolic indexes may suggest that an elevation in omentin level may be seen as being a marker for leanness, while a decreased level will underline possible situations of overweight and obesity along with their comorbidities (diabetes, cardiovascular disease, metabolic syndrome, inflammation and even cancer). However, a challenge for the future is to fully understand the multiple role played by omentin. Thus, more studies in these matter are required.
Authors and Affiliations
Magdalena Halabis, Marcin Dziedzic, Joanna Warchulinska, Iwona Kaznowska-Bystryk, Janusz Solski
Keywords
Related Articles
- EP ID EP106720
- DOI 10.1515/cipms-2015-0067
- Views 70
- Downloads 0
Formulation and evaluation of sulfadimidine and trimethoprim tablets using wet granulation technique
The objective of this study was to develop tablet formulations of sulphadimidine sodium (SDD-Na) and trimethoprim (TMP), evaluate and compare the efficiency of some excipients such as: superdisintegrant - croscarmellose...
The heparan sulfate and its diverse biological activities
Heparan sulfate (HS) is one of the most common glycosaminoglycan (GAG) in mammals. It is composed of relatively simple disaccharide subunits, which, by further modification, such as sulfation and epimerization, potential...
Multiple sclerosis – epidemiology, diagnosis, treatment and rehabilitation - a literature review
At present, multiple sclerosis is regarded as disease in which the immune system fights its own cells, in this case the nervous tissue. The World Health Organisation (WHO) estimates that 2.5 million people in the world s...
Different faces of a febrile state
Fever develops in various diseases. It is mainly associated with infectious diseases but can also occur in non-infectious ailments. Clinical symptoms are not always explicit, which can hinder the diagnosis and delay the...
The role of glycosaminoglycans and proteoglycans in atherosclerosis
Numerous studies point out to the role of glycosaminoglycans (GAG) and proteoglycans (PG) in the pathogenesis of atherosclerosis. Both GAG and PG take part in the formation of tunica intima and tunica media, contribute t...